- IHH Healthcare reported PATMI (exclude exceptional items and exclude MFRS) of MYR518mil (-9% y-o-y due to higher finance costs) on MYR6.4bn (+7% y-o-y or +18% y-o-y FX neutral) in revenue and MYR1.4bn (+2% y-o-y or +11% y-o-y FX neutral) in EBITDA.
Healthy operational performance in 2Q25, weighed down by currency translation losses but broadly in line.
- - Read this at SGinvestors.io -
- On the margins front, IHH delivered EBITDA margins of 22% with FX neutral EBITDA up in all countries except Singapore, due to the renovation at Mount Elizabeth Orchard.
Performance and outlook by Country
Malaysia:
- - Read this at SGinvestors.io -
- Margins are likely to stay stable in the mid-20s range despite payer pressure, which has eased off from its peak last year.
Singapore:
- Read more at SGinvestors.io.
